Novo Nordisk sets up innovation platform

Danish pharmaceutical giant plans slew of alliances with Chinese startups, universities and research institutions

Danish pharmaceutical giant Novo Nordisk has launched a platform called "Innovo" to further enhance its innovation capabilities in China through alliances with local universities and hospitals, pharmaceutical startups, and incubators.

The company aims to build through the program an open, integrated, efficient and collaborative research and development ecosystem to accelerate the transformation of scientific research into innovative drug discovery and development.